Cargando…
Tumor Chemosensitivity Assays Are Helpful for Personalized Cytotoxic Treatments in Cancer Patients
Tumor chemosensitivity assays (TCAs), also known as drug response assays or individualized tumor response tests, have been gaining attention over the past few decades. Although there have been strong positive correlations between the results of these assays and clinical outcomes, they are still not...
Autores principales: | Ulukaya, Engin, Karakas, Didem, Dimas, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234301/ https://www.ncbi.nlm.nih.gov/pubmed/34205407 http://dx.doi.org/10.3390/medicina57060636 |
Ejemplares similares
-
A novel 1,4-naphthoquinone-derived compound induces apoptotic cell death in breast cancer cells
por: KARAKAŞ, Didem, et al.
Publicado: (2019) -
Targeting Periostin Expression Makes Pancreatic Cancer Spheroids More Vulnerable to Natural Killer Cells
por: Karakas, Didem, et al.
Publicado: (2023) -
Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization
por: Pérez-Hernández, Marta, et al.
Publicado: (2019) -
Validation data supporting the characterization of novel copper complexes as anticancer agents
por: Acilan, Ceyda, et al.
Publicado: (2016) -
Organ-Tumor-on-a-Chip for Chemosensitivity Assay: A Critical Review
por: Kashaninejad, Navid, et al.
Publicado: (2016)